Correction: Discontinuation of Adalimumab After Achieving Remission in Patients With Established Rheumatoid Arthritis: 1-Year Outcome of the HONOR Study: Table 3

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2013-204016corr1
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

BMJ

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy